Company intelligence / Profile preview

LifeWatch

Ownership: Private
Development stage: Commercial

Overview

The company developed and commercialized FDA-cleared wireless patch-based cardiac and vital signs monitors for continuous remote patient diagnostics. Its platforms are widely used in hospitals and ambulatory care. Clinical results have shown improved physician access to actionable data for arrhythmia management. The company was acquired by BioTelemetry in July 2017; its technologies continue under the Philips Healthcare umbrella. In recent years there were legal settlements related to billing practices but no impact on product efficacy or regulatory status.

Therapeutic areas: PulmonologyCardiovascularOther
Modalities: DeviceDigital health platformRemote patient monitoring system
Industry: Physiological Monitoring

Partnerships

AliveCor partnership for mobile ECG integration

Beyond the preview

Go deeper on LifeWatch.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LifeWatch.

Explore the full profile